National trends in prescription drug expenditures and projections for 2025
For 2025, we expect overall prescription drug spending to rise by 9.0 to 11.0%, whereas in clinics and hospitals we anticipate an 11.0% to 13.0% increase and a 2.0% to 4.0% increase, respectively, compared to 2024. These national estimates of future pharmaceutical expenditure growth may not be representative of any health system because of the myriad of local factors that influence actual spending.
Authors
- Mina Tadrous (ORCID: https://orcid.org/0000-0003-1911-6129)
- Eric M. Tichy (ORCID: https://orcid.org/0000-0003-1431-0416)
- Mary Kate Newell
- James M. Hoffman (ORCID: https://orcid.org/0000-0002-2625-7766)
- Matthew H Rim
- Glen T. Schumock
- Sandra Cuéllar (ORCID: https://orcid.org/0000-0002-6864-0659)
- Thomas J. Johnson
Institutions
- ECRI Institute (US)
- St. Michael's Hospital (CA)
- St. Jude Children's Research Hospital (US)
- 3M (United States) (US)
- University of Toronto (CA)
- Avera Health (US)
- University of Illinois Chicago (US)
- Ontario Drug Policy Research Network (CA)
- IQVIA (United States) (US)
- Mayo Clinic in Arizona (US)
- The Institute of Addiction Medicine (US)
- Northwestern Medicine (US)
- Avera McKennan Hospital & University Health Center (US)
- St Michaels Hospital (GB)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1093/ajhp/zxaf092
- Citations
- 9
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 28.18